Can-Fite BioPharma (CANF) Current Assets (2014 - 2026)
Can-Fite BioPharma's Current Assets was $8 million in Q2 2026, up 5.0% from $7.62 million a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Can-Fite BioPharma came in at $9.44 million, up 5.1% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
- In earlier years, Current Assets was $8.98 million in FY2024 (-9.3%), $9.91 million in FY2023 (+8.2%), $9.16 million in FY2022 (-54.4%) and $20.07 million in FY2021 (+113.5%).
- Quarterly Current Assets has moved between $5.83 million (Q2 2024) and $20.07 million (Q4 2021) over five years.
- Compared with a year earlier, Current Assets was higher in three of the last four quarters, with growth averaging 7.9%.
- The best year-over-year quarter for Current Assets over five years was Q4 2021 (growth of 113.5%); the worst was Q4 2022 (a decline of 54.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 8.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.00 Mn |
| Dec 31, 2025 | 9.44 Mn |
| Jun 30, 2025 | 7.62 Mn |
| Dec 31, 2024 | 8.98 Mn |
| Jun 30, 2024 | 5.83 Mn |
| Dec 31, 2023 | 9.91 Mn |
| Sep 30, 2023 | 9.06 Mn |
| Jun 30, 2023 | 10.91 Mn |
| Mar 31, 2023 | 13.38 Mn |
| Dec 31, 2022 | 9.16 Mn |
| Sep 30, 2022 | 12.57 Mn |
| Jun 30, 2022 | 14.59 Mn |
| Mar 31, 2022 | 17.67 Mn |
| Dec 31, 2021 | 20.07 Mn |
| Sep 30, 2021 | 14.47 Mn |
| Jun 30, 2021 | 9.55 Mn |
| Mar 31, 2021 | 12.63 Mn |
| Dec 31, 2020 | 9.40 Mn |
| Jun 30, 2020 | 12.70 Mn |
| Dec 31, 2019 | 7.14 Mn |
API Access
Can-Fite BioPharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();